PHIO   $1.6800000000000002  -7.18% Market Closed

Phio Pharmaceuticals Corp
Total Cash 4.70M
totalCashPerShare 5.458
EBITDA -8.57M
Total Debt 0.00
quickRatio 3.085
currentRatio 3.475
Total Revenue
debtToEquity
Revenue/Share
ROA -0.61065
ROE -1.26855
grossProfits
freeCashflow -5.73M
operatingCashflow -9.06M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -1.89M
forwardPE
floatShares 547.83K
sharesOutstanding 860.72K
sharesShort 21.34K
sharesShortPriorMonth 17.06K
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.06%
heldPercentInstitutions 0.02%
Short Ratio help_outline 0.30%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue 7.395
Price To Book help_outline 0.43
earningsQuarterlyGrowth
netIncomeToCommon -8.68M
trailingEps -16.13%
forwardEps 34.02%
enterpriseToEbitda 0.22
lastDividendValue
lastDividendDate
currentQuarterEstimate 3Q 2024
institutionsCount 13
lastUpdated Nov. 6, 2024, 7:24 p.m.